Articles related to REPRODUCTIVE ENDOCRINOLOGY

Hematopoietic loss of the X chromosome in peripheral blood was associated with more than twofold the odds of failing to conceive naturally in a Japanese multicenter case-control study, with no corresponding association found in women undergoing ART.

Following a 14-year international consensus effort involving 56 professional and patient organizations, polycystic ovary syndrome is being renamed polyendocrine metabolic ovarian syndrome, with full guideline incorporation expected by 2028.

An international consensus involving more than 14,000 patients and health professionals renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS) to reflect its endocrine and metabolic features.

The periconceptional period is critical for the probability of conception, pregnancy outcomes, and long-term offspring health, and maternal dietary patterns during this period may influence fertility as well as early embryonic development.

“If I can put smarter MRI adjacent to a robotic consult and seamlessly transfer from one image to the next, it allows me to have a very efficient, safe surgery, and ensure that I’ve removed all fibroids.” – Dr. Tamatha Fenster, New York-Presbyterian

Referral rates for newly diagnosed gynecological malignancy occurred in only 14.6% of eligible patients despite attendance rates of 81.7% when referrals were made.